GW Pharmaceuticals to Present at the Stifel 2020 Virtual Healthcare Conference. LONDON and CARLSBAD, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company The biopharmaceutical company had revenue of $137.10 million for the quarter, compared to the consensus estimate of $97.66 million. GW Pharmaceuticals had a negative net margin of 11.05% and a negative return on equity of 7.50%. GW Pharmaceuticals's quarterly revenue was up 50.7% on a year-over-year basis. GW Pharmaceuticals Plc stock price up 0.92% on Friday (Updated on November 13, 2020) Buy candidate since 2020-11-06 Gain 3.63% PDF The GW Pharmaceuticals Plc stock price gained 0.92% on the last trading day (Friday, 13th Nov 2020), rising from $117.72 to $118.80. During the day the stock fluctuated 2.11% from a day low at $118.14 to a day high GW Pharmaceuticals PLC Sponsored ADR is a company in the U.S. stock market and it is a holding in 11 U.S.-traded ETFs. GWPH has around 879.1K shares in the U.S. ETF market. 13 Wall Street analysts have issued ratings and price targets for GW Pharmaceuticals in the last 12 months. Their average twelve-month price target is $185.08, predicting that the stock has a possible upside of 55.79%. The high price target for GWPH is $275.00 and the low price target for GWPH is $128.00. GW Pharmaceuticals Plc American Depositary Shares (GWPH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. GW Pharmaceuticals Plc American Depositary Shares (GWPH) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.
Stock analysis for GW Pharmaceuticals PLC (GWPH:London) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
GW Pharmaceuticals PLC is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW Pharmaceuticals Stock Price Forecast, GWPH stock price prediction. Price target in 14 days: 144.938 USD. The best long-term & short-term GW Pharmaceuticals share Get the detailed income statement for GW Pharmaceuticals plc (GWPH). Up to 10 years of financial statements. Quarterly or annual. View as % YoY growth or as % of revenue. GWPH Stock Analysis Overview . What this means: Gw Pharma ADR (GWPH) gets an Overall Rank of 51, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform. Its lead product is Epidiolex, an oral medicine for the treatment of refractory childhood epilepsies, Dravet syndrome, and Lennox-Gastaut syndrome, as well as in phase
GWPH Financial Facts See Full Income Statement See Full Balance Sheet. GW Pharmaceuticals (GWPH) Earnings. Ticker: | Expand Research on GWPH. Next EPS Date: 5/26/20 *Est. EPS Growth Rate
GW Pharma (NASDAQ: GWPH) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. Aug 18, 2017 GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used …
13 Wall Street analysts have issued ratings and price targets for GW Pharmaceuticals in the last 12 months. Their average twelve-month price target is $185.08, predicting that the stock has a possible upside of 55.79%. The high price target for GWPH is $275.00 and the low price target for GWPH is …
GW Pharmaceuticals to Present at the Stifel 2020 Virtual Healthcare Conference. LONDON and CARLSBAD, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company The biopharmaceutical company had revenue of $137.10 million for the quarter, compared to the consensus estimate of $97.66 million. GW Pharmaceuticals had a negative net margin of 11.05% and a negative return on equity of 7.50%. GW Pharmaceuticals's quarterly revenue was up 50.7% on a year-over-year basis.
Find the latest GW Pharmaceuticals Plc (GWPH) stock quote, history, news and other vital information to help you with your stock trading and investing.
View the latest GWPH stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of GW PHARMACEUTICALS PLC. Nov 11, 2020 · GWPH: GW Pharmaceuticals PLC broker recommendations. Get the latest broker recommendations from Zacks Investment Research. Find the latest GW Pharmaceuticals Plc (GWPH) stock quote, history, news and other vital information to help you with your stock trading and investing. Stock analysis for GW Pharmaceuticals PLC (GWPH:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.